Colony Group LLC Regenerx Biopharmaceuticals Inc Transaction History

Colony Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$0.19 - $0.34 $2,850 - $5,100	-15,000 Closed	0 $0
Q1 2020 May 18, 2020	BUY	$0.14 - $0.3 $2,100 - $4,500	15,000 New	15,000 $3,000
Q3 2019 Nov 26, 2019	SELL	$0.13 - $0.18 $1,300 - $1,800	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$0.16 - $0.22 $1,600 - $2,200	10,000 New	10,000 $2,000

Ticker RGRX
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,550,000
Description
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; ...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.